(Approval lapsed) Parnate Tranylcypromine 10mg tablets (Concordia Pharmaceuticals)
Section 19A approved medicine
(Approval lapsed) Parnate Tranylcypromine 10mg tablets (Concordia Pharmaceuticals)
Section 19A approval holder
Amdipharm Mercury (Australia) Pty Ltd ABN 91 118 106 684
Phone
1800 627 680
Approved until
Status
Expired
Medicines in short supply/unavailable
PARNATE tranylcypromine (as sulphate) 10mg film coated tablet blister pack - ARTG 174086
Indication(s)
Treatment of symptoms of depressive illness especially where treatment with other types of antidepressants has failed. It is not recommended for use in mild depressive states resulting from temporary situational difficulties.